Literature DB >> 8632061

Serum and cerebrospinal fluid levels of soluble adhesion molecules in multiple sclerosis: predominant intrathecal release of vascular cell adhesion molecule-1.

A G Droogan1, S A McMillan, J P Douglas, S A Hawkins.   

Abstract

Activated cerebral vascular endothelial cells express leukocyte, vascular cell, and intracellular adhesion molecules (E-selectin, VCAM-1 and ICAM-1) which facilitate leukocyte adhesion to endothelium and migration into inflammatory lesions. Paired serum and cerebrospinal fluid (CSF) levels of soluble (s) E-selectin, sVCAM-1 and sICAM-1 were determined by ELISA in patients with clinically definite MS in relapse, and patients with other inflammatory (IND) and non-inflammatory neurological disease (NIND). CSF levels of sVCAM-1 and sICAM-1 were significantly increased in MS patients compared to IND and NIND patients. Elevation of CSF sVCAM-1 in MS patients was the most marked finding (P = 0.0001) and an increased sVCAM-1 index indicated that this was due to intrathecal release of sVCAM-1. There were no differences in serum and CSF sE-selectin levels between the study groups. Measurement of the sVCAM-1 index may provide a marker of disease activity in patients with clinically definite MS.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8632061     DOI: 10.1016/0165-5728(95)00174-3

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  7 in total

1.  Intrathecal sICAM-1 production in multiple sclerosis--correlation with triple dose Gd-DTPA MRI enhancement and IgG index.

Authors:  Göksemin Acar; Fethi Idiman; Güldal Kirkali; Serkan Ozakbaş; Gülgün Oktay; Handan Cakmakçi; Egemen Idiman
Journal:  J Neurol       Date:  2005-02       Impact factor: 4.849

2.  Brain endothelial dysfunction in cerebral adrenoleukodystrophy.

Authors:  Patricia L Musolino; Yi Gong; Juliet M T Snyder; Sandra Jimenez; Josephine Lok; Eng H Lo; Ann B Moser; Eric F Grabowski; Matthew P Frosch; Florian S Eichler
Journal:  Brain       Date:  2015-09-15       Impact factor: 13.501

3.  Elevation of serum soluble intercellular adhesion molecule-1 (sICAM-1) and beta-2-microglobulin in Sjögren's syndrome.

Authors:  J Krejsek; R Slezák; O Kopecky; V Derner; C Andrys
Journal:  Clin Rheumatol       Date:  1997-03       Impact factor: 2.980

4.  Is MS an inflammatory or primary degenerative disease?

Authors:  Jacek Losy
Journal:  J Neural Transm (Vienna)       Date:  2013-09-06       Impact factor: 3.575

5.  Chitotriosidase 1 in the cerebrospinal fluid as a putative biomarker for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) progression.

Authors:  Yago Côrtes Pinheiro Gomes; Nicole Lardini Freitas; Flávia Santos Souza; Vanessa Sandim; Denise Abreu Pereira; Fábio César Sousa Nogueira; Juliana Echevarria-Lima; Ana Claudia Celestino Bezerra Leite; Marco Antonio Sales Dantas Lima; Marcus Tulius Teixeira Silva; Abelardo Queiroz Campos Araújo; Ana Carolina Paulo Vicente; Otávio Melo Espíndola
Journal:  Front Immunol       Date:  2022-08-16       Impact factor: 8.786

6.  Mucosal Administration of E-selectin Limits Disability in Models of Multiple Sclerosis.

Authors:  Jacqueline A Quandt; Pierre Becquart; Emily Kamma; John Hallenbeck
Journal:  Front Mol Neurosci       Date:  2019-08-27       Impact factor: 5.639

Review 7.  Endocannabinoid Receptors in the CNS: Potential Drug Targets for the Prevention and Treatment of Neurologic and Psychiatric Disorders.

Authors:  José Antonio Estrada; Irazú Contreras
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.